Charles W. Newton sold $6K of KROS stock

Charles W. Newton, Dir of Keros Therapeutics, Inc. (KROS), sold 551 shares of KROS stock worth $6K, per an SEC Form 4 filed Aug 20, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 18, 2026, 2 days before it was made public.

KROS has moved -5.0% since the trade date, from $10.61 to $10.08 (Nov 12, 2026 close).